41 related articles for article (PubMed ID: 22253408)
1. Mitochondrial Cardiomyopathy: The Roles of mt-tRNA Mutations.
Ding Y; Gao B; Huang J
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362661
[TBL] [Abstract][Full Text] [Related]
2. Letter to the Editor: Diagnosing Mitochondrial Encephalomyopathy With Lactic Acidosis and Stroke-Like Episodes (MELAS) Requires Not Only Phenotypic But Also Genotypic Verification.
Finsterer J; Zarrouk-Mahjoub S
Ochsner J; 2018; 18(1):4-5. PubMed ID: 29559858
[No Abstract] [Full Text] [Related]
3. MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis.
Hsu YR; Yogasundaram H; Parajuli N; Valtuille L; Sergi C; Oudit GY
Heart Fail Rev; 2016 Jan; 21(1):103-116. PubMed ID: 26712328
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics of anesthesia in patients with MELAS syndrome: Case report of anesthesia in video-assisted thoracoscopy].
Haas A; Wappler F
Anaesthesist; 2015 Oct; 64(10):747-53. PubMed ID: 26314741
[TBL] [Abstract][Full Text] [Related]
5. Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy.
Florian A; Ludwig A; Stubbe-Dräger B; Boentert M; Young P; Waltenberger J; Rösch S; Sechtem U; Yilmaz A
J Cardiovasc Magn Reson; 2015 May; 17(1):40. PubMed ID: 26001801
[TBL] [Abstract][Full Text] [Related]
6. Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management.
Bates MG; Bourke JP; Giordano C; d'Amati G; Turnbull DM; Taylor RW
Eur Heart J; 2012 Dec; 33(24):3023-33. PubMed ID: 22936362
[TBL] [Abstract][Full Text] [Related]
7. Up to date in pharmacological treatment of dilated cardiomyopathy.
Ginghina C; Teodorescu A; Stoian I; Serban M; Ghiorghiu I; Wohlfart K
Rom J Intern Med; 2004; 42(1):3-13. PubMed ID: 15529591
[TBL] [Abstract][Full Text] [Related]
8. [Mitochondrial cardiomyopathy].
Tanaka M
Nihon Rinsho; 2002 Apr; 60 Suppl 4():306-11. PubMed ID: 12013873
[No Abstract] [Full Text] [Related]
9. Are Angiotensin-converting enzyme inhibitors and beta-blockers ineffective in children with dilated cardiomyopathy and heart failure?
Singh TP; Almond C
J Am Coll Cardiol; 2010 Aug; 56(10):823; author reply 823-4. PubMed ID: 20797500
[No Abstract] [Full Text] [Related]
10. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
[TBL] [Abstract][Full Text] [Related]
11. [Peculiarities of cardiac failure treatment in diffuse myocarditis and dilated cardiomyopathy].
Gurevich MA; Iankovskaia MO; Gordienko BV; Mravian SR; Grigor'eva NM
Klin Med (Mosk); 1997; 75(1):48-50. PubMed ID: 9082062
[No Abstract] [Full Text] [Related]
12. Mitochondrial A3243G mutation with manifestation of acute dilated cardiomyopathy.
Stalder N; Yarol N; Tozzi P; Rotman S; Morris M; Fellmann F; Schwitter J; Hullin R
Circ Heart Fail; 2012 Jan; 5(1):e1-3. PubMed ID: 22253408
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
